A 26-year-old woman presented to the subfertility clinic with a history of absent periods for 1 year with galactorrhea. Further investigations revealed a pituitary microadenoma. Her partners SFA is normal. What is the best treatment to improve her fertility? A) Laparoscopy and ovarian drilling B) Ovulation induction with clomiphene citrate C) Ovulation induction with human menopausal gonadotropin D) Pituitary surgery E) Treatment with cabergoline
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
The answer is E) Treatment with cabergoline.
Explanation
This patient has hyperprolactinaemia caused by a pituitary microadenoma (prolactinoma), which is causing her amenorrhoea (anovulation) and galactorrhoea. The mechanism is straightforward: excess prolactin suppresses GnRH pulsatility → loss of LH/FSH → anovulation → infertility.
Why cabergoline is correct
The root cause of her infertility is hyperprolactinaemia. Treating the underlying hormonal disorder restores the entire hypothalamic-pituitary-ovarian axis:
"For symptomatic microadenomas, therapeutic goals include control of hyperprolactinemia, reduction of tumor size, restoration of menses and fertility, and resolution of galactorrhea." — Harrison's Principles of Internal Medicine, 22E
"Cabergoline (0.5–1.0 mg twice weekly) achieves normoprolactinemia and resumption of normal gonadal function in ~80% of patients with microadenomas; galactorrhoea improves or resolves in 90% of patients." — Harrison's, 22E
Cabergoline (an ergoline-derived dopamine D2 agonist) is preferred over bromocriptine because it:
- Is longer-acting (twice weekly dosing vs. multiple daily doses)
- Has higher D2 receptor affinity and better efficacy
- Has fewer adverse effects (nausea, dizziness, vomiting)
- Normalises prolactin and shrinks the tumour in most cases
Once prolactin is normalised, spontaneous ovulation typically resumes — no additional ovulation induction is needed.
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| A) Laparoscopy + ovarian drilling | For polycystic ovary syndrome (PCOS) with clomiphene resistance — not relevant here |
| B) Clomiphene citrate | Anti-oestrogen that works at the hypothalamus — won't work while high prolactin is still suppressing GnRH; also doesn't treat the cause |
| C) hMG (gonadotrophins) | Bypasses the hypothalamus/pituitary but doesn't address the prolactinoma; reserved for resistant cases after dopamine agonist failure |
| D) Pituitary surgery | Reserved for dopamine-agonist–resistant or intolerant cases, or large tumours with mass effect; not first-line for a microadenoma |
Answer: E — Cabergoline corrects the underlying hyperprolactinaemia, restores GnRH pulsatility and ovulation, and resolves galactorrhoea, making it the best treatment to improve fertility in this scenario.
— Harrison's Principles of Internal Medicine, 22E, "Prolactinoma" section
43. A 43-year-old mother of 2 children came to the subfertility clinic seeking advice on getting pregnant again. She had undergone LRT after her 2nd pregnancy. She also has mild endometriosis. What is the best option for her? A) IUI B) Decline further treatment. C) IVF D) Ovum donation and surrogacy E) Reversal of LRT
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
The answer is C) IVF.
Explanation
This question requires integrating three key factors:
| Factor | Clinical significance |
|---|---|
| Age 43 | Significantly reduced ovarian reserve; declining egg quality |
| Previous laparoscopic tubal ligation/resection (LRT) | Tubes are the mechanical barrier to conception |
| Mild endometriosis | An additional subfertility factor |
Why IVF is the best option
IVF bypasses the need for patent tubes entirely — eggs are retrieved directly from the ovaries and fertilised in the lab, then transferred to the uterus. This makes it the most appropriate strategy when tubal factor is the primary barrier.
IVF is specifically indicated for:
- Tubal disease (including post-sterilisation status)
- Endometriosis-associated infertility
- Advanced maternal age (where time is critical)
"The assisted reproductive technologies… are commonly used to treat infertile couples with tubal disease, endometriosis… In vitro fertilization involves ovarian hyperstimulation, retrieval of oocytes, fertilization, embryo culture, and embryo transfer." — Goldman-Cecil Medicine
Why not reversal of LRT (Option E)?
Tubal reversal (reanastomosis) is a valid option in younger women with sufficient remaining tubal length, but it is not appropriate here for two reasons:
- Age 43 — ovarian reserve is already compromised. IVF success at 41–42 is ~12% per cycle (Goldman-Cecil). Even with patent tubes, natural conception rates at 43 are extremely low. Reversal surgery would expose her to operative risk with minimal expected benefit.
- Mild endometriosis is an additional pelvic factor that would reduce spontaneous conception rates even after successful reversal.
- The time taken to recover from reversal surgery further erodes the small window of fertility she has left.
In younger women (under ~35–38) with good ovarian reserve and a long tubal remnant, reversal can be cost-effective. At 43, IVF is faster, avoids major surgery, and can also allow preimplantation genetic testing (PGT-A) to screen embryos for aneuploidies — a significant advantage given her age-related risk of chromosomal abnormalities.
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| A) IUI | Requires patent tubes — not possible post-LRT |
| B) Decline treatment | The question asks for the best option; withholding is not justified when a valid treatment exists |
| D) Ovum donation + surrogacy | Her uterus is intact and functional; own-egg IVF should be tried first (ovum donation is reserved for ovarian failure or repeated IVF failure) |
| E) Reversal of LRT | Suboptimal at age 43; IVF is more time-efficient and has better outcomes in this age group |
Answer: C — IVF is the best option, as it bypasses both the absent tubal patency and the endometriosis factor, and is the most time-efficient approach given her age of 43.
— Goldman-Cecil Medicine, "Assisted Reproductive Technologies"; Berek & Novak's Gynecology, "Infertility Operations"
A 30 year old female presents with a 2 year history of subfertility. USS revealed three intramural fibroids, each of size 2 cm. What most appropriate management? (a) Conservative management (b) Laparoscopic myomectomy (c) Open myomectomy (d) Treat with GnRH analogue (e) Uterine artery embolization
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
The answer is (a) Conservative management.
Explanation
This question is testing knowledge of the relationship between intramural fibroids and fertility, specifically whether surgical intervention improves outcomes.
Key facts from evidence
The textbook evidence here is clear and directly applicable:
"Intramural fibroids may slightly decrease fertility, but removal does not increase fertility."
"Analysis of studies that routinely used hysteroscopy to confirm clear non-distortion of the cavity by intramural fibroids found ongoing pregnancy/live birth rates were not significantly different compared to controls (RR 0.73; 95% CI, 0.38–1.40). Removal of intramural or subserosal fibroids did not improve ongoing pregnancy/live birth rates (RR 1.67; 95% CI, 0.75–3.72)."
"Myomectomy may involve operative and anaesthetic risks, risks of infection or postoperative adhesions, a slight risk of uterine rupture during pregnancy, an increased likelihood that a caesarean section will be recommended for delivery… Therefore, until intramural fibroids are shown to decrease and myomectomy to increase fertility rates, surgery should be undertaken with reluctance." — Berek & Novak's Gynecology
Applying this to the case
| Feature | Significance |
|---|---|
| Three intramural fibroids, 2 cm each | Small, not distorting the uterine cavity |
| No mention of submucosal distortion | Cavity-distorting fibroids are the ones that harm fertility |
| Age 30, 2 years subfertility | Other causes of subfertility should be investigated |
The fibroids are small (2 cm), intramural, and not described as distorting the uterine cavity. The evidence does not support that removing them improves fertility, and surgery introduces its own risks.
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| B) Laparoscopic myomectomy | Myomectomy for non-cavity-distorting intramural fibroids does not improve fertility rates; introduces surgical risk |
| C) Open myomectomy | Even more invasive; same lack of fertility benefit; reserved for large/multiple fibroids or when laparoscopy is not feasible |
| D) GnRH analogue | Shrinks fibroids temporarily but they regrow after stopping; not a fertility treatment and can suppress ovulation |
| E) Uterine artery embolization | Contraindicated in women desiring future pregnancy due to risk of early ovarian failure and adverse pregnancy outcomes |
Answer: A — Conservative management is most appropriate. Small, non-cavity-distorting intramural fibroids do not warrant surgical intervention in a woman seeking fertility, as myomectomy has not been shown to improve pregnancy rates and carries its own procedural risks.
— Berek & Novak's Gynecology, "Fertility" (Fibroids), p. 510–511; Schwartz's Principles of Surgery, 11E
Regarding hysterosalpingogram, a) Done before 10 days from menstruation b) Submucosal fibroids are a contraindication c) Methylene blue dye is used d) Reveals a bicornuate uterus e) Can identify the site of tubal obstruction
Finding Sources
Finding Sources
Reading File
Reading File
The answer is (e) Can identify the site of tubal obstruction.
Explanation
HSG (hysterosalpingography) is a fluoroscopic X-ray procedure in which radio-opaque contrast dye is injected through the cervix to outline the uterine cavity and fallopian tubes. When dye fails to pass beyond a certain point, the exact site of blockage (cornual/isthmic/ampullary/fimbrial) is visible on the image — this is one of its primary clinical uses in subfertility investigation.
"Contrast dye is injected under fluoroscopy to visualize the uterine cavity, fallopian tube architecture, and tubal patency… By flushing inspissated mucus and debris, the HSG procedure may have therapeutic value." — Berek & Novak's Gynecology, p. 2059
Analysing each option
(a) Done before 10 days from menstruation — FALSE
HSG is performed between cycle days 7 and 12 (after menses have ended, before ovulation). The correct timing is after menstruation has stopped, not before 10 days — the wording here is misleading and the stated reason is to avoid irradiating an early pregnancy and to take advantage of thinner proliferative-phase endometrium.
"HSG is performed after menses but prior to ovulation between cycle days 7 and 12." — Berek & Novak's Gynecology
(b) Submucosal fibroids are a contraindication — FALSE
Submucosal fibroids are not a contraindication; in fact, HSG can reveal them as filling defects. The actual contraindications are active/suspected PID and known hydrosalpinges (risk of exacerbating infection).
"HSG should be avoided in the setting of known hydrosalpinges and/or current or suspected PID." — Berek & Novak's Gynecology
(c) Methylene blue dye is used — FALSE
HSG uses radio-opaque iodinated contrast dye (water-based or oil-based), visualised under fluoroscopy. Methylene blue is a different dye used in laparoscopy (chromopertubation) to assess tubal patency directly under vision — it is not radio-opaque and cannot be used with X-ray.
(d) Reveals a bicornuate uterus — PARTIALLY TRUE but not the best answer
HSG can show uterine shape abnormalities, but it cannot definitively distinguish a bicornuate uterus (a true structural anomaly with external fundal indentation) from a septate uterus (an internal septum, normal external contour). This distinction requires MRI or laparoscopy/hysteroscopy combined. So while HSG can suggest a uterine anomaly, it cannot reliably diagnose bicornuate uterus specifically.
(e) Can identify the site of tubal obstruction — TRUE ✓
This is the most accurate and unambiguous statement. HSG demonstrates the entire length of both tubes under fluoroscopy; when dye stops flowing, the site of obstruction (proximal, mid-tube, or distal/fimbrial) is clearly delineated. This guides further management (e.g., proximal blockage may be amenable to selective catheterisation; distal fimbrial disease may need salpingostomy or IVF).
Answer: E — HSG can identify the site of tubal obstruction, which is one of its principal advantages in subfertility workup.
— Berek & Novak's Gynecology, "Hysterosalpingography", p. 2058–2059; Pfenninger & Fowler's Procedures for Primary Care
A Hysterosalpingogram of a32-year-old subfertile woman revealed bilateral obstruction at cornual ends. What is the next step in management? a) Intrauterine insemination b) Counseling on adoption c) In Vitro fertilization d) Laparoscopy and dye test e) Tubal surgery
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
The answer is (d) Laparoscopy and dye test.
Rationale
This question is specifically about the next step, not the definitive treatment. The key clinical issue is that cornual (proximal) obstruction on HSG has a significant false-positive rate due to tubal spasm.
Why laparoscopy and dye test comes first
HSG has a sensitivity of only 65% and specificity of 83% for tubal patency (Berek & Novak's). Proximal/cornual "obstruction" on HSG is particularly unreliable:
"Even laparoscopy has been reported to have a false positive rate of 11% for proximal tubal occlusion when resected tubal segments are examined pathologically."
"Abnormal findings on HSG can be validated by direct visualization on laparoscopy using chromopertubation, which involves the transcervical installation of a dye such as indigo carmine to directly visualize tubal patency and fimbrial architecture." — Berek & Novak's Gynecology, p. 2060
Cornual obstruction on HSG is frequently caused by tubal spasm at the uterotubal junction — this is a functional, not anatomical, blockage. Laparoscopy with chromopertubation (dye test) under general anaesthesia — when the patient is relaxed — can confirm or refute the obstruction.
Additionally, laparoscopy simultaneously:
- Excludes pelvic pathology (endometriosis, adhesions) that HSG cannot show
- Allows selective tubal catheterisation at the same sitting if true proximal occlusion is confirmed
- Informs whether IVF or tubal surgery is the appropriate definitive step
Why not go straight to IVF (Option c)?
IVF would be the definitive treatment if true bilateral tubal occlusion is confirmed. But before committing a young 32-year-old patient to IVF — which is expensive, invasive, and carries risks — the suspected obstruction must first be confirmed by the gold-standard test (laparoscopy). If laparoscopy reveals the tubes are patent (spasm on HSG), IVF is unnecessary entirely.
"Laparoscopy is considered the gold standard for diagnosing tubal and peritoneal disease." — Berek & Novak's Gynecology
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| a) IUI | Requires patent tubes — cannot work with tubal obstruction |
| b) Counselling on adoption | Premature; true obstruction not yet confirmed |
| c) IVF | Correct definitive treatment if obstruction confirmed, but laparoscopy should come first to rule out false positive |
| e) Tubal surgery | Premature; requires confirmation of true obstruction and assessment of tubal architecture first |
Answer: D — Laparoscopy and dye test is the next step to confirm (or refute) the bilateral cornual obstruction seen on HSG, before committing to IVF or surgery.
— Berek & Novak's Gynecology, "Laparoscopy" & "Treatment of Tubal Factor Infertility", p. 2060; Harrison's Principles of Internal Medicine 22E, "Tubal Factor Infertility"
This is a shared conversation. Sign in to Orris to start your own chat.